CIK 0001810560 · Non-accelerated filer<br>Smaller reporting company
REVELATION BIOSCIENCES, INC.
Sign in to watch- Ticker
- REVB
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 843898466
- Phone
- 650-800-3717
- Business address
- 4660 LAJOLLA VILLAGE DRIVE, SUITE 100, SAN DIEGO, CA, 92122
- Former names
- Petra Acquisition Inc.
Securities
- REVB Common Stock Nasdaq
- REVBW Warrant Nasdaq
- 8-K Event Acquisition or sale completed · Unregistered share sale · Change in control · Executive or director change · Bylaws or fiscal year change · Shell status change
- 8-K Event Regulation FD disclosure
- 8-K Event Bylaws or fiscal year change · Shareholder vote results
- 4 Insider Changes in Ownership
- SC 13G/A Stake Amended Statement of Ownership
- 8-K Event Material agreement · New debt or obligation · Regulation FD disclosure · Other events
- DEFA14A Proxy Proxy Materials
- 8-K Event Other events
- 424B3 Offering Prospectus
- EFFECT Other Notice of Effectiveness
- CORRESP Other Correspondence Between Filers and SEC Staff
- S-4/A Deal Registration Statement - Business Combination
- S-4/A Deal Registration Statement - Business Combination
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
- DEFA14A Proxy Proxy Materials
- 8-K Event Other events
- CORRESP Other Correspondence Between Filers and SEC Staff
- S-4/A Deal Registration Statement - Business Combination
- 3 Insider Initial Statement of Ownership
Page 16 of 20 · 389 filings